Abstract
The use of intravitreal anti vascular endothelial growth factor (anti-VEGF) drugs such as pegaptanib, ranibizumab and bevacizumab has been widely reported to treat complications such as macular edema and rubeosis. During the past few years they have also been used as an adjuvant therapy to reduce intraocular bleeding during vitrectomy in eyes with proliferative diabetic retinopathy as well as to reduce the occurrence of vitreous haemorrhages in vitrectomized eyes and facilitate glaucoma surgery.
In this paper we review the use of anti VEGF drugs in the surgical management of diabetic retinopathy related complications.
Keywords: Diabetic retinopathy, Proliferative diabetic retinopathy, Diabetic macular edema, VEGF, Bevacizumab, Ranibizumab, Pegaptanib, Bevasiranib, VEGF trap, Vitrectomy, Laser photocoagulation, Phacoemulsification, Glaucoma surgery
Current Diabetes Reviews
Title: Intravitreal Anti-VEGF Drugs as Adjuvant Therapy in Diabetic Retinopathy Surgery
Volume: 7 Issue: 3
Author(s): Javier A. Montero, Jose M Ruiz-Moreno and Maria E. Correa
Affiliation:
Keywords: Diabetic retinopathy, Proliferative diabetic retinopathy, Diabetic macular edema, VEGF, Bevacizumab, Ranibizumab, Pegaptanib, Bevasiranib, VEGF trap, Vitrectomy, Laser photocoagulation, Phacoemulsification, Glaucoma surgery
Abstract: The use of intravitreal anti vascular endothelial growth factor (anti-VEGF) drugs such as pegaptanib, ranibizumab and bevacizumab has been widely reported to treat complications such as macular edema and rubeosis. During the past few years they have also been used as an adjuvant therapy to reduce intraocular bleeding during vitrectomy in eyes with proliferative diabetic retinopathy as well as to reduce the occurrence of vitreous haemorrhages in vitrectomized eyes and facilitate glaucoma surgery.
In this paper we review the use of anti VEGF drugs in the surgical management of diabetic retinopathy related complications.
Export Options
About this article
Cite this article as:
A. Montero Javier, M Ruiz-Moreno Jose and E. Correa Maria, Intravitreal Anti-VEGF Drugs as Adjuvant Therapy in Diabetic Retinopathy Surgery, Current Diabetes Reviews 2011; 7 (3) . https://dx.doi.org/10.2174/157339911795843104
DOI https://dx.doi.org/10.2174/157339911795843104 |
Print ISSN 1573-3998 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6417 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Fibromyalgia: The Prototypical Central Sensitivity Syndrome
Current Rheumatology Reviews Inducible Nitric Oxide Synthase - Time for Reappraisal
Current Drug Targets - Inflammation & Allergy Carnitine Metabolism and Deficit - When Supplementation is Necessary?
Current Pharmaceutical Biotechnology Effects of Peroxyl Radicals on Contractility of Rabbit Aorta and Guinea Pig Atria
Endocrine, Metabolic & Immune Disorders - Drug Targets Oligonucleotide-based Gene Therapy for Cardiovascular Disease Are Oligonucleotide Therapeutics Novel Cardiovascular Drugs
Current Drug Targets The Immune System Regulation in Sepsis: From Innate to Adaptive
Current Protein & Peptide Science Pharmacological Strategies for Neuroprotection in Traumatic Brain Injury
Mini-Reviews in Medicinal Chemistry Mechanisms of Action of Hypertonic Saline Resuscitation in Severe Sepsis and Septic Shock
Endocrine, Metabolic & Immune Disorders - Drug Targets Immunotherapy of Pancreatic Carcinoma
Reviews on Recent Clinical Trials Adrenomedullin and Nitric Oxide: Implications for the Etiology and Treatment of Primary Brain Tumors
CNS & Neurological Disorders - Drug Targets Older and Newer Strategies for the Pharmacological Management of Agitation in Patients with Bipolar Disorder or Schizophrenia
CNS & Neurological Disorders - Drug Targets L-Dopa Prodrugs: An Overview of Trends for Improving Parkinsons Disease Treatment
Current Pharmaceutical Design ATP-Sensitive Potassium Channel Modulators and Cardiac Arrhythmias: An Update
Current Pharmaceutical Design Laparoscopic Surgery for Pheochromocytoma and Paraganglioma Removal: A Retrospective Analysis of Anaesthetic Management
Current Hypertension Reviews Peptides as Carrier for Tumor Diagnosis and Treatment
Current Medicinal Chemistry - Anti-Cancer Agents Endogenous Cardioprotective Agents: Role in Pre and Postconditioning
Current Drug Targets Urocortins: Take Them to Heart
Current Medicinal Chemistry - Cardiovascular & Hematological Agents Nitric Oxide and Dietary Factors: Part III Minerals, Vitamins and Other Dietary and Lifestyle Factors
Vascular Disease Prevention (Discontinued) Inhibitory Effect of PD-1/PD-L1 and Blockade Immunotherapy in Leukemia
Combinatorial Chemistry & High Throughput Screening Inherited Copper Transport Disorders: Biochemical Mechanisms, Diagnosis, and Treatment
Current Drug Metabolism